Home Applications 006530 Application 006530
Type NDA
Sponsor MYLAN SPECIALITY LP Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 003 AVC SULFANILAMIDE CREAM;VAGINAL 15% Yes Yes 004 AVC SULFANILAMIDE SUPPOSITORY;VAGINAL 1.05GM No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N006530-003 AVC SULFANILAMIDE 15% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CREAM / VAGINAL RLD 1987-01-27 N006530-004 AVC SULFANILAMIDE 1.05GM SUPPOSITORY / VAGINAL 1987-01-27
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 3 of 3 · 90 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N006530-003 AVC 15% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CREAM / VAGINAL RLD 1987-01-27 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N006530-004 AVC 1.05GM SUPPOSITORY / VAGINAL 1987-01-27 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N006530-003 AVC 15% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CREAM / VAGINAL RLD 1987-01-27 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 N006530-004 AVC 1.05GM SUPPOSITORY / VAGINAL 1987-01-27 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N006530-003 AVC 15% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CREAM / VAGINAL RLD 1987-01-27 e64feba35796…2022-09-29 23:25 UTC 2022-09 N006530-004 AVC 1.05GM SUPPOSITORY / VAGINAL 1987-01-27 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N006530-003 AVC 15% CREAM / VAGINAL RLD 1987-01-27 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N006530-004 AVC 1.05GM SUPPOSITORY / VAGINAL 1987-01-27 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N006530-003 AVC 15% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CREAM / VAGINAL RLD 1987-01-27 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N006530-004 AVC 1.05GM SUPPOSITORY / VAGINAL 1987-01-27 a50c72e98297…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 1 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0037-6631 AVC sulfanilamide Meda Pharmaceuticals NDA Current
Documents# Document, Submission type, Date table Document Submission type Date 32943 SUPPL 2013-01-23